miR-21 has been identified to target at the tumor suppressing genes, such as the protein tyrosine phosphatase (PTEN), programmed cell death 4 (PDCD4), and B cell translocation gene 2 (BTG2). The gene discussed is PDCD4; the disease is neoplasm.